Xeris Pharmaceuticals (XERS)
(Delayed Data from NSDQ)
$1.76 USD
-0.02 (-1.12%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.76 0.00 (0.00%) 6:10 PM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | -11.11% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.38 |
Next Year | -0.17 |
EPS (TTM) | -0.45 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 41.56M | 45.12M | 184.29M | 218.68M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 44.00M | 47.60M | 194.20M | 230.40M |
Low Estimate | 37.97M | 43.89M | 176.70M | 195.20M |
Year ago Sales | 33.20M | 38.01M | 163.91M | 184.29M |
Year over Year Growth Est. | 25.17% | 18.70% | 12.43% | 18.66% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.11 | -0.38 | -0.17 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.14 | -0.11 | -0.40 | -0.13 |
High Estimate | -0.11 | -0.09 | -0.29 | 0.00 |
Low Estimate | -0.14 | -0.12 | -0.47 | -0.35 |
Year ago EPS | -0.12 | -0.14 | -0.45 | -0.38 |
Year over Year Growth Est. | 0.00% | 21.43% | 15.56% | 54.74% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.11 | -0.38 | -0.17 |
7 Days Ago | -0.12 | -0.11 | -0.38 | -0.17 |
30 Days Ago | -0.12 | -0.10 | -0.37 | -0.16 |
60 Days Ago | -0.07 | -0.05 | -0.25 | -0.01 |
90 Days Ago | -0.07 | -0.04 | -0.27 | -0.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.12 | -0.44 | -0.21 |
Zacks Consensus Estimate | -0.12 | -0.11 | -0.38 | -0.17 |
Earnings ESP | 0.00% | -11.63% | -15.79% | -22.09% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.09 | -0.14 | -0.12 | NA |
Estimate | -0.09 | -0.12 | -0.13 | -0.17 | NA |
Difference | -0.01 | 0.03 | -0.01 | 0.05 | 0.02 |
Surprise | -11.11% | 25.00% | -7.69% | 29.41% | 8.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more